1. Duncan, Anna R, Vitobello, Antonio, Collins, Stephan C, Yalcin, Binnaz, Agrawal, Pankaj B. 2020. Heterozygous Variants in KDM4B Lead to Global Developmental Delay and Neuroanatomical Defects. In American journal of human genetics, 107, 1170-1177. doi:10.1016/j.ajhg.2020.11.001. https://pubmed.ncbi.nlm.nih.gov/33232677/
2. Wilson, Cailin, Krieg, Adam J. 2019. KDM4B: A Nail for Every Hammer? In Genes, 10, . doi:10.3390/genes10020134. https://pubmed.ncbi.nlm.nih.gov/30759871/
3. Wu, Meng-Jen, Chen, Chih-Jung, Lin, Ting-Yu, Kung, Hsing-Jien, Wang, Wen-Ching. 2021. Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer. In Theranostics, 11, 7779-7796. doi:10.7150/thno.58729. https://pubmed.ncbi.nlm.nih.gov/34335964/
4. Ueda, Takeshi, Kanai, Akinori, Komuro, Akiyoshi, Kawazu, Masahito, Okada, Hitoshi. 2021. KDM4B promotes acute myeloid leukemia associated with AML1-ETO by regulating chromatin accessibility. In FASEB bioAdvances, 3, 1020-1033. doi:10.1096/fba.2021-00030. https://pubmed.ncbi.nlm.nih.gov/34938963/